NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research ProgramGlobeNewsWire · 2 days ago
NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Stock Short Interest Climbs 135.8%Defense World · Oct 13, 2026
NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing TechnologyGlobeNewsWire · Oct 8, 2026
NeuroOne (NASDAQ: NMTC) secures a $4.5M order as revenue climbs againDefense World · Oct 6, 2026
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase OrderGlobeNewsWire · Oct 5, 2026
Innovative Eyewear (NASDAQ:LUCY) and NeuroOne Medical Technologies (NASDAQ:NMTC) Head-To-Head ReviewDefense World · Oct 4, 2026NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 13, 2026 | -$0.21 | -$0.23 | Miss |
| May 12, 2026 | -$0.23 | -$0.25 | Miss |
| Feb 17, 2026 | -$0.24 | -$0.17 | Beat |
| Dec 17, 2025 | -$0.24 | -$0.30 | Miss |
| Aug 14, 2025 | -$0.30 | -$0.18 | Beat |
| May 13, 2025 | -$0.54 | -$0.42 | Beat |